Evidence map›Paper›PMID 41563944›Full record

ReviewChemistry & biodiversity2026

Reviewing Marine Bioactive Compounds From the Red Sea: Advancing Therapeutic Applications While Navigating Translational and Conservation Challenges.

Mohammed F Hawwal, Nadeem Sayyed, Omer I Fantoukh, Gadah A AlHamoud, Sarfaraz Ahmed, Saleh I Alqasoumi, Perwez Alam

Abstract readReview
In one paragraph

Review in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammed F HawwalDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Nadeem SayyedDepartment of Pharmacology, Dr. R. G. Bhoyar Institute of Pharmaceutical Education & Research, Wardha, India.ORCID https://orcid.org/0000-0003-0517-4934
Omer I FantoukhDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Gadah A AlHamoudDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Sarfaraz AhmedDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Saleh I AlqasoumiDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.
Perwez AlamDepartment of Pharmacognosy, College of Pharmacy, King Saud University, Riyadh, Saudi Arabia.ORCID https://orcid.org/0000-0003-0668-2236

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Red Sea, a biologically rich marine ecosystem, is a promising source of novel bioactive compounds with significant therapeutic potential. This review analyzes a decade of research on the isolation, characterization, and biological activities of compounds obtained from sponges, corals, microalgae, seaweeds, marine fish, and microorganisms. These bioactive molecules, including alkaloids, glycosides, terpenes, and peptides, exhibit antimicrobial, anticancer, anti-inflammatory, and neuroprotective properties. Various extraction techniques, ranging from traditional solvent extraction to advanced methods such as supercritical fluid and ultrasound-assisted extraction, aid in their isolation. Meanwhile, chromatographic purification and bioassay-guided fractionation enhance their identification. However, challenges such as limited availability, complex extraction processes, and regulatory constraints hinder the clinical translation of these technologies. Addressing these barriers requires innovative extraction strategies, advanced characterization techniques, and interdisciplinary approaches that integrate marine biology with emerging technologies, such as deep learning. Future research should focus on exploring molecular interactions within coral reef ecosystems, unraveling marine bacterial diversity, and implementing conservation strategies to protect the Red Sea's unique biodiversity while accelerating drug discovery.

Indexed as

Antineoplastic AgentsAquatic OrganismsBiological ProductsAnimalsConservation of Natural ResourcesDrug DiscoveryHumansIndian OceanMicroalgaeAntineoplastic AgentsBiological Productsbioactive compoundsdrug discoverymarine organismsmicroalgaeRed Sea biodiversitytherapeutic potential

Identifiers

PMID41563944
PMCPMC13420837

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.